Publications by authors named "L M Hansmann"

Claim this Profile
M
Mutant p53-specific CD8TCR-therapy combined with a CD4TCR prevents relapse of cancer and outgrowth of micrometastases.
Vasiliki Anastasopoulou, Hans Schreiber, Ching-En Lee, Kazuma Kiyotani, Leo Hansmann

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST.
Maximilian Merz, Nico Gagelmann, Samih Smaili, Sarah Flossdorf, Sandra Sauer, Leo Hansmann

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorder.
Helena Hansmann, Chiara Henkel, Matthias A Fante, Dennis C Harrer, Stefanie Heidemanns, Leo Hansmann

Am J Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma.
Michael Winkelmann, Sandeep S Raj, Michael D Jain, Gloria Iacoboni, Fabian Müller, Leo Hansmann

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire.
Leonie Rosenberger, Leo Hansmann, Vasiliki Anastasopoulou, Steven P Wolf, Kimberley Drousch

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis